Two functionally different kininogens in human plasma

Same author

[Panuveitis under dabrafenib/trametinib treatment for malignant cutaneous melanoma persisting after completion of treatment].

Die Ophthalmologie·2024

Same author

[Central retinal vein thrombosis in a 21-year-old man-What is the cause?]

Die Ophthalmologie·2022

Same author

Into the Blue: First in Man Data on Diving Physiology in Fontan Patients.

Pediatric cardiology·2022

Same author

[Rapidly progressive neuropathy, diffuse pain and pseudohallucinations in a young female patient].

Der Nervenarzt·2022

Same author

[Overlap syndrome between primary T cell-mediated vasculitis of the brainstem and chronic lymphocytic inflammation with pontocerebellar perivascular enhancement responsive to steroids (CLIPPERS)].

Der Nervenarzt·2020

Same author

[Isolated metamorphopsia and visual pseudohallucinations in a patient with anti-NMDA receptor encephalitis].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2020

Same journal

Classification and biological distribution of histamine receptor sub-types. 1975.

Agents and actions·1994

Same journal

Metiamide--an orally active histamine H2-receptor antagonist. 1973.

Agents and actions·1994

Same journal

A brief survey of the history of inflammation. 1978.

Agents and actions·1994

Same journal

The discovery of librium. 1972.

Agents and actions·1994

Same journal

Notes and documents concerning the discovery of LSD. 1970.

Agents and actions·1994

Same journal

Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41,468), a selective 5-HT2-receptor antagonist. 1982.

Agents and actions·1994

Related Experiment Videos

Two functionally different kininogens in human plasma

Related Concept Videos

[Panuveitis under dabrafenib/trametinib treatment for malignant cutaneous melanoma persisting after completion of treatment].

[Central retinal vein thrombosis in a 21-year-old man-What is the cause?]

Into the Blue: First in Man Data on Diving Physiology in Fontan Patients.

[Rapidly progressive neuropathy, diffuse pain and pseudohallucinations in a young female patient].

[Overlap syndrome between primary T cell-mediated vasculitis of the brainstem and chronic lymphocytic inflammation with pontocerebellar perivascular enhancement responsive to steroids (CLIPPERS)].

[Isolated metamorphopsia and visual pseudohallucinations in a patient with anti-NMDA receptor encephalitis].

Classification and biological distribution of histamine receptor sub-types. 1975.

Metiamide--an orally active histamine H2-receptor antagonist. 1973.

A brief survey of the history of inflammation. 1978.

The discovery of librium. 1972.

Notes and documents concerning the discovery of LSD. 1970.

Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41,468), a selective 5-HT2-receptor antagonist. 1982.

Related Experiment Videos

Two functionally different kininogens in human plasma

Related Concept Videos

Related Articles

[Panuveitis under dabrafenib/trametinib treatment for malignant cutaneous melanoma persisting after completion of treatment].

[Central retinal vein thrombosis in a 21-year-old man-What is the cause?]

Into the Blue: First in Man Data on Diving Physiology in Fontan Patients.

[Rapidly progressive neuropathy, diffuse pain and pseudohallucinations in a young female patient].

[Overlap syndrome between primary T cell-mediated vasculitis of the brainstem and chronic lymphocytic inflammation with pontocerebellar perivascular enhancement responsive to steroids (CLIPPERS)].

[Isolated metamorphopsia and visual pseudohallucinations in a patient with anti-NMDA receptor encephalitis].

Classification and biological distribution of histamine receptor sub-types. 1975.

Metiamide--an orally active histamine H2-receptor antagonist. 1973.

A brief survey of the history of inflammation. 1978.

The discovery of librium. 1972.

Notes and documents concerning the discovery of LSD. 1970.

Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41,468), a selective 5-HT2-receptor antagonist. 1982.